In combination with other markers and tests such as ALT, AFP, ultrasound, and gastric endoscopy, GP73 detection may help rule out early-stage LC or HCC in chronic HBV-infected patients. This evidence concerns the gene AFP and laryngotracheoesophageal cleft.